Trocchia MA

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

2 papers

ArticleKetamine

Beyond symptom reduction: Intranasal esketamine is associated with improved quality of life in treatment-resistant depression.

Pompili M, Sarubbi S, Di Biase G +5

Europe PMC2026
ArticleKetamine

Efficacy of Intranasal Esketamine in Treatment-Resistant Depression: A Six-Month Real-World Follow-Up Study of Depressive Symptoms, Hopelessness, and Suicide Risk.

Pompili M, Trocchia MA, Longhini L +5

Europe PMC2025